Is Psilocybin Legal in the US? Federal and State Status Explained
Psilocybin remains federally illegal in the United States as a Schedule I substance. However, several states have established limited legal frameworks for therapeutic use. Here’s what you need to know.
Is Psilocybin Legal in the US? The Short Answer
No, psilocybin is not legal under United States federal law. Psilocybin, the primary psychoactive compound in so-called “magic mushrooms,” is classified as a Schedule I controlled substance under the Controlled Substances Act (CSA), 21 U.S.C. § 812. This means the federal government considers it to have a high potential for abuse, no currently accepted medical use, and a lack of accepted safety for use under medical supervision. There is no Food and Drug Administration (FDA) approval for any psilocybin-containing medication. This article provides general information and is not legal advice.
Federal Law: Schedule I Status and Its Implications
Psilocybin’s Schedule I status has far-reaching consequences. At the federal level, it is illegal to manufacture, possess, distribute, or use psilocybin for any purpose outside of tightly regulated research. Federal penalties can be severe, including fines and imprisonment. The Drug Enforcement Administration (DEA) enforces these restrictions, and the FDA has not approved psilocybin for medical use as of this writing.
Despite growing research interest, psilocybin remains in the same legal category as substances like heroin and LSD. This restricts access for patients and researchers, and means any use outside of an approved clinical trial or research protocol is subject to federal prosecution. For more on the federal regulatory landscape, see our psychedelic law guide and latest briefings.
State-Level Changes: Where Is Psilocybin Legal or Decriminalized?
While federal law is clear, some states have begun to carve out exceptions for psilocybin, particularly for therapeutic use. These programs operate in a legal gray area, as they do not override federal law, but federal enforcement has historically been limited where state law provides a clear regulatory framework.
- Oregon: In 2020, Oregon voters passed Measure 109, authorizing the regulated adult use of psilocybin in licensed service centers under professional supervision. The program began accepting clients in 2023. Psilocybin remains illegal outside of these regulated settings.
- Colorado: In 2022, Colorado voters approved Proposition 122, creating a pathway for supervised psilocybin services and decriminalizing personal use, possession, and cultivation for adults. Full implementation is ongoing through 2024–2025.
- New Mexico: In 2026, New Mexico enacted the Medical Psilocybin Act, establishing a statewide medical psilocybin program for specific conditions under licensed clinicians. This marks the first legislated medical framework for psilocybin in the US.
Several other cities (such as Denver, Oakland, and Santa Cruz) have deprioritized enforcement of psilocybin laws, but this does not amount to full legalization. For a detailed map and program links, see our psychedelic research landscape and state-by-state guides.
Psilocybin and the FDA: Research, Clinical Trials, and Approval Status
Psilocybin is not FDA-approved for any medical indication. However, research is advancing rapidly. Two major phase 3 clinical programs are underway:
- COMPASS Pathways (COMP360): This pharmaceutical-grade psilocybin formulation is in phase 3 trials for treatment-resistant depression, with results expected through 2025–2026.
- Usona Institute (IPR001): Usona is conducting phase 3 trials for major depressive disorder.
Both programs have received “Breakthrough Therapy” designation from the FDA, which signals promising preliminary evidence but does not confer legal status or approval. Until the FDA approves a psilocybin-based medication, it remains illegal outside of research settings. For more on the pipeline and trial landscape, see our research overview and latest clinical trial briefings.
Common Questions About Psilocybin Legality
Can I possess or use psilocybin mushrooms for personal use?
Under federal law, possession or use of psilocybin mushrooms is illegal. Some localities have deprioritized enforcement, but this does not prevent federal prosecution. Only in Oregon, Colorado, and New Mexico (within specific programs) is some form of supervised or medical use permitted.
What about religious or spiritual use?
There are narrow religious exemptions for certain groups (such as for peyote in the Native American Church), but no comparable federal exemption exists for psilocybin. Some groups have sought religious protections, but legal recognition is rare and untested in most courts.
Is it legal to participate in a clinical trial?
Yes, if you are enrolled in an FDA-approved clinical trial or research protocol, psilocybin use is legal within that context. Outside of approved research, it is not.
Are there any legal risks for researchers?
Researchers must comply with DEA and FDA regulations, including obtaining Schedule I licenses and following strict security and reporting protocols. Noncompliance can result in loss of licensure and criminal penalties. For research compliance tools, see our tools directory.
What’s Next? Navigating the Changing Legal Landscape
The legal status of psilocybin in the US is evolving. While federal law remains unchanged, state-level reforms and ongoing clinical trials may influence future policy. The FDA’s recent announcement of an approval pathway for psychedelics signals potential change, but until an FDA-approved medication is available, psilocybin remains federally illegal.
For those interested in the latest developments, policy changes, and research updates, consult our briefing feed and beginner’s guide. Always seek expert legal advice before engaging in any activity involving controlled substances.